Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. - Wikidata - wikimedia - TriplyDB

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q33254109

about

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells Cytoplasmic poly(A) binding protein C4 serves a critical role in erythroid differentiation Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.Statistical use of argonaute expression and RISC assembly in microRNA target identification Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels.Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression.Multiset Statistics for Gene Set Analysis.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.The prognostic impact of RAP2A expression in patients with early and locoregionally advanced nasopharyngeal carcinoma in an endemic area.A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci.GWAS signals across the HLA regions: revealing a clue for common etiology underlying infectious tumors and other immunity diseases HLA associations with nasopharyngeal carcinoma.FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts Functional genomics as a tool in virus research.Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis The progress on genetic analysis of nasopharyngeal carcinoma.Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to differentiation status and tissue origin.Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.Identification of genes involved in Epstein-Barr virus-associated nasopharyngeal carcinoma Glutamate Decarboxylase 1 Overexpression as a Poor Prognostic Factor in Patients with Nasopharyngeal Carcinoma.PDZ binding kinase (PBK) is a theranostic target for nasopharyngeal carcinoma: driving tumor growth via ROS signaling and correlating with patient survival Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.Proof for EBV's sustaining role in Burkitt's lymphomas.Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.

P2860

Q27863380-40B4B1A9-CA6E-48BC-AD90-67B47D739875 Q28483778-7514ADFE-B70B-4634-AF77-A52B636F8667 Q28589228-5BE53DA7-E846-4BC0-95C4-E114E6687AFF Q31083741-3FF01ACC-4435-4A5F-9DE4-E6A94B6DD320 Q33285000-EFA44E28-238B-40A2-AF3C-DDC181C5F11C Q33506607-410800E2-CA84-4901-A6B0-303612C01E4F Q33688934-EE200769-C020-473B-B6B6-D55EE1654EC7 Q33889053-AC92BB8B-D6F8-4AB2-A40C-CC17F5BB495C Q34056327-83265C32-71CC-49DD-B822-E5AE9537D2AE Q34081186-ACA7EF92-2DC5-4F09-87B8-BB436FE4264D Q34345591-2EBCF7CC-0A26-4D8A-ACBF-77ECEBE41618 Q34507851-79604065-C4F1-4DFC-BB10-16F036A8006F Q35140295-57D3BDBA-4CEC-498A-9775-C7A45FE59A96 Q35191816-B22A31AB-1050-4252-9ADB-E1CED3614873 Q35511501-FCCB5444-26CF-435E-B216-3BBFEA8FEF4F Q35597559-12D1A90B-BAB2-44AF-8486-8186C7FE8CD6 Q35677629-C7C42194-F217-44B3-B584-697474350937 Q35795725-50BC1493-F410-46AD-91BA-D670B9E0E690 Q35808018-A747E652-78D8-4C93-921F-C477A7658DF9 Q35826481-46241800-6EE4-4F57-8743-985A8C092294 Q35885173-82CE1F49-DABC-4E5A-A476-8EC1827C0731 Q36053844-BBED7B29-DADE-4710-8002-CADB8C207359 Q36125265-C1489DC5-5D98-4B58-A508-DF09A7D3434A Q36164237-47197686-6FD3-4A77-B301-B0B0990605F1 Q36207171-E5ED619B-03EB-404D-BCD9-131FAE43C6EF Q36256160-2573C461-FCA4-4F5D-B98A-E2A49F76B39C Q36299700-A3F7B605-4D3D-4B04-BF19-92B2E3250719 Q36338606-9D1807F8-B732-469C-A6EF-8E09FE8D3D21 Q36445020-20BD7C6F-07AC-48FB-9133-2D67F5B36505 Q36540111-373823B5-7D57-4F1B-889D-064F088DE6C2 Q36742929-473E832E-C985-4616-B721-6D8DA94D2385 Q37015716-8F54EC44-638E-4299-9F54-CE7F74695BA9 Q37117769-3FC7193D-3589-4A2C-86E2-6C6FDB5A0D7B Q37240280-896F4772-15A5-4792-BBC0-139528784053 Q37289393-C38B7632-53E8-4F7C-93E7-A3D51F4204CB Q37290566-59D7596D-76B9-41BC-A48E-80C685BC8857 Q37295736-075E9F5E-9599-4B35-9B78-0675591F1988 Q37301260-79CBD624-5DE1-4850-9F75-6744ED693CC7 Q37463625-E239EAC6-FBC8-4FF9-8499-B54FAC208E6B Q37534984-41BB4B98-EED5-4039-86F1-CDDF50A51F33

P2860

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q33254109

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@ast

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@en

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@nl

type

label

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@ast

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@en

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@nl

prefLabel

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@ast

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@en

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@nl

P1433

Q33254109-40EEE082-E701-4D60-A4EE-ADC10376746A

P1476

Q33254109-962A4D9D-77C2-45AC-B89D-56825DA3DBCE

P2093

Q33254109-0294F06C-8288-4F88-99F2-FB1CDBEF7823

Q33254109-0A5D0F61-9EDD-4C48-A716-7723A0D4B489

Q33254109-16D42621-303B-4A38-9AEA-CE5E18534989

Q33254109-29F88EDB-3254-4E76-B9DB-479AA5AB9CA5

Q33254109-2C8F31D8-7F87-4ADE-BB3E-948FF1D72E0C

Q33254109-408F848A-1906-41E2-B594-469411BFEF31

Q33254109-860316DE-1060-4FB8-98B8-CCF32C6C900D

Q33254109-96FCA261-4D5D-4D90-AADA-40F665213570

Q33254109-C4A27205-FBAB-4FDC-8178-FFAFB366CDB0

Q33254109-C5FD2774-168F-47A1-BC1A-79ADBA707E6D

P304

Q33254109-5E6DEB2C-FEA3-48BA-BA4B-3263BCB0E608

P31

Q33254109-C5703B59-DFAF-4D38-8BE3-58DB59C0EDCF

P356

Q33254109-C0831310-93B0-4450-B563-2593230B17C1

P407

Q33254109-6F4F2855-6EDA-4B4E-9753-F84B7CC18B82

P433

Q33254109-6E36B6E5-064C-41D3-B1FC-A047C66AE53C

P478

Q33254109-B9540A82-6862-4C48-92A9-A01AC7C8A821

P50

Q33254109-95C80323-8CAB-4A37-82FA-6F47FE0C6CB2

P577

Q33254109-B11D570B-FFAF-4595-95D4-759C33A21F28

P5875

Q33254109-DA7834BE-3D92-483E-BF8C-686EB147496F

P698

Q33254109-9F6E093B-9994-4676-BE5F-4C5184BC8D32

P356

0008-5472.CAN-05-4399

P1433

Cancer Research

P1476

Genome-wide expression profili ...... n in nasopharyngeal carcinoma.

@en

P2093

Bill Sugden

http://www.w3.org/2001/XMLSchema#string

Chien-Jen Chen

http://www.w3.org/2001/XMLSchema#string

David B Dahl

http://www.w3.org/2001/XMLSchema#string

I-How Chen

http://www.w3.org/2001/XMLSchema#string

Johan A den Boon

http://www.w3.org/2001/XMLSchema#string

Meng Chen

http://www.w3.org/2001/XMLSchema#string

Michael A Newton

http://www.w3.org/2001/XMLSchema#string

Paul Ahlquist

http://www.w3.org/2001/XMLSchema#string

Srikumar Sengupta

http://www.w3.org/2001/XMLSchema#string

William H Westra

http://www.w3.org/2001/XMLSchema#string

P304

7999-8006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-4399

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Allan Hildesheim

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6875783

http://www.w3.org/2001/XMLSchema#string

P698

16912175

http://www.w3.org/2001/XMLSchema#string